Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs

No abstract is available for this paper.

• Publication year

  2003

• Venue

  EMBO Reports

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.embor.embor840PMID 12740604PMCID PMC1319196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7

  2003cited by this paper
• siRNAs can function as miRNAs

  2003cited by this paper
• siRNAs can function as miRNAs.

  2003cited by this paper
• A promising new anti-HCV protease inhibitor.

  2003cited by this paper
• Gene expression: RNA interference in adult mice

  2002cited by this paper
• Modulation of HIV-1 replication by RNA interference

  2002cited by this paper
• Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase*

  2002cited by this paper
• Medicine: Silencing viruses with RNA

  2002influential reference
• U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells

  2002cited by this paper
• Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference1

  2002cited by this paper
• siRNA-mediated gene silencing in vitro and in vivo

  2002cited by this paper
• Short interfering RNA confers intracellular antiviral immunity in human cells

  2002cited by this paper
• A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

  2002cited by this paper
• Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

  2002cited by this paper
• [Epidemiology of hepatitis C].

  2002cited by this paper
• US FTC probes practices of 100 companies

  2001cited by this paper
• RNA interference--2001.

  2001cited by this paper
• Effect of Alpha Interferon on the Hepatitis C Virus Replicon

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate

  2001cited by this paper
• RNA Interference

  2000cited by this paper
• Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

  1999cited by this paper
• Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

  1999cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors.

  1997cited by this paper
• Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation.

  1997cited by this paper
• Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.

  1996cited by this paper
• Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.

  1996cited by this paper
• Almost the entire 5′ non‐translated region of hepatitis C virus is required for cap‐independent translation

  1995cited by this paper
• Vaccination of chimpanzees against infection by the hepatitis C virus.

  1994cited by this paper
• Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism

  1993cited by this paper
• Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

  1992influential reference
• Internal ribosome entry site within hepatitis C virus RNA

  1992cited by this paper
• Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

  1991cited by this paper
• Genetic organization and diversity of the hepatitis C virus.

  1991cited by this paper
• Mechanisms of antiviral action of interferon.

  1983cited by this paper
• Epidemiology of hepatitis.

  1965cited by this paper

• Revisiting immunology textbooks: Considering potential insights based on the role of RNA-guided antiviral defense

  2024cites this paper
• Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review

  2024cites this paper
• Advances in Nanozymes as a Paradigm for Viral Diagnostics and Therapy

  2023cites this paper
• DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning

  2023cites this paper
• A novel concept of human antiviral protection: It's all about RNA (Review).

  2022cites this paper
• Sp1A novel concept of human antiviral protection: It's all about RNA (Review)

  2022cites this paper
• RNA interference is the basis of human antiviral defense

  2022cites this paper
• Effect of siRNA targeting dengue virus genes on replication of dengue virus: an in vitro experimental study

  2021cites this paper
• shRNA transgenic swine display resistance to infection with the foot-and-mouth disease virus

  2021cites this paper
• DisCoVering potential candidates of RNAi-based therapy for COVID-19 using computational methods

  2021cites this paper
• SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad

  2021cites this paper
• siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses

  2021cites this paper
• Consensus small interfering RNA targeted to stem-loops II and III of IRES structure of 5′ UTR effectively inhibits virus replication and translation of HCV sub-genotype 4a isolates from Saudi Arabia

  2020influential citation
• Calcium Phosphate Nanoparticles-Based Systems for RNAi Delivery: Applications in Bone Tissue Regeneration

  2020cites this paper
• Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy

  2020cites this paper
• miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers

  2019cites this paper
• Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells

  2019cites this paper
• Silencing HCV Replication in Its Reservoir

  2018cites this paper
• Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication

  2018cites this paper
• Retinoid derivative Tp80 exhibits anti‐hepatitis C virus activity through restoration of GI‐GPx expression

  2017cites this paper
• Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress

  2017cites this paper
• Four Aromatic Sulfates with an Inhibitory Effect against HCV NS3 Helicase from the Crinoid Alloeocomatella polycladia

  2017cites this paper
• In vitro inhibitory analysis of consensus siRNAs against NS3 gene of hepatitis C virus 1a genotype.

  2017cites this paper
• Inhibition of Coxsackievirus A24 in permissive Hep2 cells by small interfering RNA (siRNA)

  2017cites this paper
• Anti‐adipogenic and antiviral effects of l‐carnitine on hepatitis C virus infection

  2017cites this paper
• Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.

  2017cites this paper
• Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.

  2017cites this paper
• Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection

  2017cites this paper
• Current and Emerging Themes in the Structural Analysis of Viral RNA Genomes: Applications for the Development of Novel Therapeutic Drugs

  2017cites this paper
• Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation

  2016cites this paper
• Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.

  2016cites this paper
• Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System

  2016cites this paper
• Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer

  2016cites this paper
• The therapeutic potential of new investigational hepatitis C virus translation inhibitors

  2016cites this paper
• shRNA inhibits the expression of chicken telomerase reverse transcriptase in MDCC-MSB1 cells.

  2016cites this paper
• Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90

  2016cites this paper
• FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53

  2015cites this paper
• Gene Therapy for Hepatitis C Virus Infection

  2015cites this paper
• Involvement of FKBP6 in hepatitis C virus replication

  2015cites this paper
• Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase

  2015cites this paper
• Application of RNA Interference (RNAi) in The Treatment of Human Infectious Diseases

  2015cites this paper
• Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.

  2015cites this paper
• Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys

  2015cites this paper
• Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver artificial primary microrna mimics

  2015cites this paper
• Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients.

  2014cites this paper
• Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers.

  2014cites this paper
• The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels.

  2014influential citation
• Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53

  2014cites this paper
• Inhibition of Hepatitis C Virus in Chimeric Mice by Short Synthetic Hairpin RNAs: Sequence Analysis of Surviving Virus Shows Added Selective Pressure of Combination Therapy

  2014cites this paper
• RNAi to Treat Chronic Hepatitis C Infection

  2014cites this paper
• HEPATITIS C VIRUS GENOTYPING IN SULAIMANI GOVERNORATE

  2014cites this paper
• PBDE: Structure-Activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase

  2014cites this paper
• RNA interference-based therapeutics: molecular platforms for infectious diseases.

  2014cites this paper
• On the release of small RNAs and viruses from hepatocytes

  2014cites this paper
• Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

  2014cites this paper
• Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision

  2014cites this paper
• Towards RNAi based therapy of liver diseases : diversity and complexity of shRNA and miRNA processing and functions

  2013cites this paper
• Add‐on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C

  2013cites this paper
• Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity

  2013cites this paper
• Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice

  2013cites this paper
• Characteristics of short double stranded RNA against hepatitis C virus: a literature-based analysis

  2013cites this paper
• Prospects for nucleic acid-based therapeutics against hepatitis C virus.

  2013cites this paper
• Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication

  2013cites this paper
• Comparative analysis of T-cell depletion method for clinical immunotherapy-anti-hepatitis c effects of natural killer cells via interferon-γ production.

  2013cites this paper
• [Recent progress in adenovirus vectors: focusing on VA-deleted AdV].

  2013cites this paper
• Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus

  2013cites this paper
• Molecular detection, phylogenetic analysis and designing of siRNA against Potato Virus X

  2013cites this paper
• Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells

  2012cites this paper
• Regulation of Hepatitis C virus replication and gene expression by the MAPK-ERK pathway

  2012cites this paper
• Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model

  2012cites this paper
• Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia

  2012cites this paper
• Emerging Clinical Applications and Pharmacology of RNA

  2012cites this paper
• Nanoparticle-based artificial RNA silencing machinery for antiviral therapy

  2012cites this paper
• Design of Synthetic shRNAs for Targeting Hepatitis C: A New Approach to Antiviral Therapeutics

  2012influential citation
• Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells.

  2012cites this paper
• Novel Anti-viral Strategies for Hepatitis C

  2012cites this paper
• STRATEGIES FOR PREVENTION AND TREATMENT OF HEPATITIS C VIRUS INFECTION

  2012cites this paper
• Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C

  2012cites this paper
• In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.

  2012cites this paper
• Crimean-Congo Hemorrhagic Fever Virus: Strategies to Combat with an Emerging Threat to Human

  2012cites this paper
• Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.

  2012cites this paper
• A novel minicircle vector based system for inhibting the replication and gene expression of enterovirus 71 and coxsackievirus A16.

  2012cites this paper
• Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

  2012cites this paper
• Liver: A Major Target Organ in Gene Therapy

  2011cites this paper
• RNA interference as therapeutics for hepatocellular carcinoma.

  2011cites this paper
• siRNAs: Potential therapeutic agents against Hepatitis C Virus

  2011cites this paper
• Analysis of Interferon Signaling by Infectious Hepatitis C Virus Clones with Substitutions of Core Amino Acids 70 and 91

  2011cites this paper
• Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.

  2011cites this paper
• Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3−CD56+ and CD3+CD56+ Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity

  2011cites this paper
• Mapping the function of the NS3 protein of African horsesickness virus using RNAi and yeast two-hybrid analyses

  2011cites this paper
• Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA

  2011cites this paper
• Identification of Novel N-(Morpholine-4-Carbonyloxy) Amidine Compounds as Potent Inhibitors against Hepatitis C Virus Replication

  2011cites this paper
• Inhibitory Effect of a Triterpenoid Compound, with or without Alpha Interferon, on Hepatitis C Virus Infection

  2011cites this paper
• Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs

  2011cites this paper
• HCV entry receptors as potential targets for siRNA-based inhibition of HCV

  2011cites this paper
• Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes

  2011cites this paper
• AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?

  2011cites this paper
• The mitochondria mediate the induction of NOX1 gene expression by aldosterone in an ATF-1-dependent manner

  2011cites this paper
• Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes.

  2011cites this paper
• MicroRNA-like antivirals.

  2011cites this paper